Corporate
Description
  • Value proposition

    Get updates around our progress and challenges to champion long-term health đź’™ #DrivingChange

    Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 66,000 people in 80 countries and markets its products in around 170 countries. For more information visit novonordisk.com.

    This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.

    Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
    https://www.novonordisk.com/contact-us/find-local-information.html

    For other customer complaints, please contact us here:
    https://www.novonordisk.com/contact-us.html

    Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.

    Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.

    Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

    Pharmaceuticals, Insulin, obesity, Rare Diseases, and Diabetes

  • Novo Nordisk | driving change to defeat serious chronic diseases

    Novo Nordisk | driving change to defeat serious chronic diseases

  • https://www.novonordisk.com/
Entity interactions BETA
Entity TypeTweets Articles
Genomic Expression Inc Genomic Expression Inc
Biotechnology Research, biotech, deeptech
Other

28 Jan 2025


Harvard Office of Technology Development (OTD) Harvard Office of Technology Development (OTD)
Research Services
Other

9 Jan 2025


Envisagenics Envisagenics
Biotechnology Research, biotech, deeptech
Other

16 Jan 2025


Washington Clean Energy Testbeds Washington Clean Energy Testbeds
Renewable Energy Semiconductor Manufacturing, cleantech, energytech
Other

7 Jan 2025


Microsoft Cloud Microsoft Cloud
Software Development, it services
Other

25 Jan 2025


The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School
Research Services, healthtech
Other

24 Jan 2025


Recursion Recursion
Biotechnology Research, biotech, deeptech
Other

19 Jan 2025


Agora Health Agora Health
healthtech
Other

21 Jan 2025


MTC - Medical Training Center - Rouen MTC - Medical Training Center - Rouen
healthtech, edtech
Other

11 Jan 2025


Norges forskningsrĂĄd Norges forskningsrĂĄd
Government Administration
Other

18 Jan 2025


Radars
Loading...